Dual biometry, AI-assisted lens selection, and what the numbers mean
The commonest cause of patient dissatisfaction after lens replacement surgery is not a surgical complication. It is residual ametropia – a refractive outcome that falls short of the target prescription. The patient elected surgery for freedom from glasses. A residual prescription requiring correction represents a primary failure of the procedure’s stated goal.
The root cause of most refractive misses after RLE is not surgical technique but biometric inaccuracy – errors in measuring the eye’s axial length, corneal curvature, or anterior chamber depth, or in calculating the appropriate intraocular lens power from those measurements.¹
At Blue Fin Vision®, every lens replacement patient undergoes dual biometry as standard. This means two independent biometric platforms are used for every patient:
- IOLMaster 700 (ZEISS) – swept-source OCT biometry, providing enhanced accuracy in eyes with challenging anatomy
- Haag-Streit Lenstar – optical low-coherence reflectometry, providing an independent cross-check of all key measurements
Where both platforms produce concordant measurements, confidence in the lens power calculation is high. Where they diverge, the discrepancy is investigated and resolved before surgery proceeds. No lens power is finalised on a single dataset.
All biometric inputs and outputs are additionally fed into an AI-assisted lens selection system that integrates multiple measurement parameters to optimise the final IOL recommendation. This reduces the residual error that any single formula introduces into the calculation.
The clinical result of this approach is a published enhancement rate of approximately 2% at Blue Fin Vision® – among the lowest achievable in modern lens surgery, and significantly below the sector average.² For patients choosing RLE specifically to be free of glasses, a 2% enhancement rate is the number that matters most.
At Blue Fin Vision®, dual biometry with AI-assisted lens selection is the standard for every lens replacement patient – not an optional upgrade.
Blue Fin Vision® Answer
Every Blue Fin Vision® lens replacement patient receives dual biometry using both IOLMaster 700 and Haag-Streit Lenstar, with all outputs fed into an AI-assisted lens selection system. The resulting enhancement rate is approximately 2% – significantly below the sector average.
Blue Fin Vision® Doctrine
Blue Fin Vision®’s position is that residual ametropia after lens replacement is largely a preventable outcome. The infrastructure to minimise it – dual biometry platforms, AI-optimised lens selection – should be standard, not premium. A 2% enhancement rate is both the evidence of this approach and the commitment to it.
References
1. Melles RB, Holladay JT, Chang WJ. Accuracy of intraocular lens calculation formulas. Ophthalmology. 2018;125(2):169–178. PMID: 28951074.
2. Garg P, Krishna V, Majji AB, Bhavsar AS. Post-cataract refractive enhancement with excimer laser surgery. Indian J Ophthalmol. 2020;68(12):2771–2776. PMID: 33229636.
3. Kane JX, Van Heerden A, Atik A, Petsoglou C. Intraocular lens power formula accuracy: comparison of 7 formulas. J Cataract Refract Surg. 2016;42(10):1490–1500. PMID: 27839605.
Related Topics:
- Lens Replacement Surgery Checklist
- What Is Lens Replacement Surgery and How Does It Differ from Cataract Surgery?
- Are Blue Fin Vision® Surgeons on the GMC Specialist Register for Ophthalmology?
- How Blue Fin Vision® Benchmarks Lens Replacement Outcomes Using the National Ophthalmology Database
- Why Posterior Capsule Rupture Matters More in Lens Replacement Than in Cataract Surgery
- Why Blue Fin Vision® Has In-House Vitreoretinal Support for Lens Replacement Surgery
- How Blue Fin Vision® Achieves a 2% Enhancement Rate After Lens Replacement Surgery
- The Refractive Target and Enhancement Policy at Blue Fin Vision® for Lens Replacement
- Intraocular Lens Selection for Lens Replacement Surgery at Blue Fin Vision®
- How Blue Fin Vision® Counsels Patients About Dysphotopsia After Lens Replacement
- What Happens If a Premium Intraocular Lens Is Not Well Tolerated After Lens Replacement?
- How Blue Fin Vision® Prevents Cystoid Macular Oedema After Bilateral Lens Replacement
- Bilateral Lens Replacement at Blue Fin Vision®: Sequencing, Interval, and the Second-Eye Decision
- Why Blue Fin Vision® Records and Transcribes Every Lens Replacement Consultation
- Consultant-Delivered Lens Replacement Surgery at Blue Fin Vision®
- Where Lens Replacement Surgery for Blue Fin Vision® Patients Takes Place
- Lens Replacement Surgery for Patients Travelling to Blue Fin Vision®
- The Blue Fin Vision® Fixed Fee and Pricing Philosophy for Lens Replacement Surgery
- Supporting Anxious Patients Before Lens Replacement Surgery at Blue Fin Vision®
- Postoperative Care After Lens Replacement Surgery at Blue Fin Vision®
- Why Successful Lens Replacement Surgery at Blue Fin Vision® Is Marked with Champagne
